It is for this reason we have elected to assess plaque growth and responses to the viral anti-inflammatory serpin, Serp-2, in a range of models to determine whether the effects of this protein will be evident in different animal models of arterial disease in order to assess whether this will be of more widespread potential interest. This evidence concerns the gene SERP2 and arterial disorder.